nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—ABCB1—peripheral nervous system neoplasm	0.308	1	CbGaD
Ketamine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0595	0.135	CbGbCtD
Ketamine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0451	0.102	CbGbCtD
Ketamine—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0329	0.0747	CbGbCtD
Ketamine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0328	0.0746	CbGbCtD
Ketamine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0328	0.0746	CbGbCtD
Ketamine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0314	0.0714	CbGbCtD
Ketamine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0255	0.0579	CbGbCtD
Ketamine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0227	0.0517	CbGbCtD
Ketamine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0197	0.0447	CbGbCtD
Ketamine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.019	0.0431	CbGbCtD
Ketamine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0183	0.0415	CbGbCtD
Ketamine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0171	0.0388	CbGbCtD
Ketamine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.014	0.0318	CbGbCtD
Ketamine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0135	0.0306	CbGbCtD
Ketamine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0131	0.0297	CbGbCtD
Ketamine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0128	0.0292	CbGbCtD
Ketamine—TACR1—trigeminal nerve—peripheral nervous system neoplasm	0.011	0.113	CbGeAlD
Ketamine—TACR1—vagus nerve—peripheral nervous system neoplasm	0.0103	0.106	CbGeAlD
Ketamine—Clonus—Cisplatin—peripheral nervous system neoplasm	0.00961	0.107	CcSEcCtD
Ketamine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00876	0.0199	CbGbCtD
Ketamine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00839	0.0191	CbGbCtD
Ketamine—TACR1—cranial nerve—peripheral nervous system neoplasm	0.00785	0.0807	CbGeAlD
Ketamine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00769	0.0175	CbGbCtD
Ketamine—GRIN2C—nerve—peripheral nervous system neoplasm	0.00531	0.0546	CbGeAlD
Ketamine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00525	0.0119	CbGbCtD
Ketamine—GRIN1—ganglion—peripheral nervous system neoplasm	0.00435	0.0447	CbGeAlD
Ketamine—GRIN2B—nerve—peripheral nervous system neoplasm	0.0042	0.0431	CbGeAlD
Ketamine—GRIN2B—ganglion—peripheral nervous system neoplasm	0.00415	0.0426	CbGeAlD
Ketamine—TACR1—nerve—peripheral nervous system neoplasm	0.00402	0.0414	CbGeAlD
Ketamine—TACR1—ganglion—peripheral nervous system neoplasm	0.00397	0.0408	CbGeAlD
Ketamine—GRIN2A—nerve—peripheral nervous system neoplasm	0.00367	0.0377	CbGeAlD
Ketamine—GRIN2A—ganglion—peripheral nervous system neoplasm	0.00362	0.0372	CbGeAlD
Ketamine—OPRD1—ganglion—peripheral nervous system neoplasm	0.00323	0.0332	CbGeAlD
Ketamine—GRIN2C—brainstem—peripheral nervous system neoplasm	0.00228	0.0234	CbGeAlD
Ketamine—OPRM1—nerve—peripheral nervous system neoplasm	0.00223	0.0229	CbGeAlD
Ketamine—OPRM1—ganglion—peripheral nervous system neoplasm	0.0022	0.0226	CbGeAlD
Ketamine—GRIN2D—brainstem—peripheral nervous system neoplasm	0.00212	0.0218	CbGeAlD
Ketamine—GRIN1—brainstem—peripheral nervous system neoplasm	0.00189	0.0194	CbGeAlD
Ketamine—GRIN2B—brainstem—peripheral nervous system neoplasm	0.0018	0.0185	CbGeAlD
Ketamine—Nystagmus—Vincristine—peripheral nervous system neoplasm	0.00175	0.0195	CcSEcCtD
Ketamine—TACR1—brainstem—peripheral nervous system neoplasm	0.00173	0.0178	CbGeAlD
Ketamine—Cystitis noninfective—Tretinoin—peripheral nervous system neoplasm	0.00168	0.0186	CcSEcCtD
Ketamine—Cystitis noninfective—Isotretinoin—peripheral nervous system neoplasm	0.00168	0.0186	CcSEcCtD
Ketamine—Cystitis—Tretinoin—peripheral nervous system neoplasm	0.00166	0.0184	CcSEcCtD
Ketamine—Cystitis—Isotretinoin—peripheral nervous system neoplasm	0.00166	0.0184	CcSEcCtD
Ketamine—Cystitis noninfective—Melphalan—peripheral nervous system neoplasm	0.00165	0.0184	CcSEcCtD
Ketamine—Cystitis—Melphalan—peripheral nervous system neoplasm	0.00163	0.0182	CcSEcCtD
Ketamine—SLC6A2—nerve—peripheral nervous system neoplasm	0.00163	0.0168	CbGeAlD
Ketamine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00161	0.0166	CbGeAlD
Ketamine—GRIN2A—brainstem—peripheral nervous system neoplasm	0.00157	0.0162	CbGeAlD
Ketamine—Bladder pain—Isotretinoin—peripheral nervous system neoplasm	0.00155	0.0172	CcSEcCtD
Ketamine—Bladder pain—Tretinoin—peripheral nervous system neoplasm	0.00155	0.0172	CcSEcCtD
Ketamine—Bladder pain—Melphalan—peripheral nervous system neoplasm	0.00153	0.017	CcSEcCtD
Ketamine—DRD2—nerve—peripheral nervous system neoplasm	0.00149	0.0153	CbGeAlD
Ketamine—DRD2—ganglion—peripheral nervous system neoplasm	0.00147	0.0151	CbGeAlD
Ketamine—Laryngospasm—Etoposide—peripheral nervous system neoplasm	0.00136	0.0151	CcSEcCtD
Ketamine—Cystitis noninfective—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.0141	CcSEcCtD
Ketamine—Cystitis—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.0139	CcSEcCtD
Ketamine—Apnoea—Etoposide—peripheral nervous system neoplasm	0.0012	0.0133	CcSEcCtD
Ketamine—Bladder pain—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.0131	CcSEcCtD
Ketamine—GRIN2C—cerebellum—peripheral nervous system neoplasm	0.00112	0.0116	CbGeAlD
Ketamine—PTGS1—ganglion—peripheral nervous system neoplasm	0.00107	0.011	CbGeAlD
Ketamine—GRIN2D—cerebellum—peripheral nervous system neoplasm	0.00104	0.0107	CbGeAlD
Ketamine—OPRM1—brainstem—peripheral nervous system neoplasm	0.000957	0.00984	CbGeAlD
Ketamine—GRIN1—cerebellum—peripheral nervous system neoplasm	0.000931	0.00957	CbGeAlD
Ketamine—GRIN2B—cerebellum—peripheral nervous system neoplasm	0.000888	0.00913	CbGeAlD
Ketamine—Nystagmus—Epirubicin—peripheral nervous system neoplasm	0.000796	0.00884	CcSEcCtD
Ketamine—GRIN2A—cerebellum—peripheral nervous system neoplasm	0.000777	0.00798	CbGeAlD
Ketamine—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.00077	0.00854	CcSEcCtD
Ketamine—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.00077	0.00854	CcSEcCtD
Ketamine—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.00076	0.00843	CcSEcCtD
Ketamine—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00075	0.00833	CcSEcCtD
Ketamine—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00075	0.00833	CcSEcCtD
Ketamine—Nystagmus—Doxorubicin—peripheral nervous system neoplasm	0.000737	0.00818	CcSEcCtD
Ketamine—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.000707	0.00785	CcSEcCtD
Ketamine—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.000707	0.00785	CcSEcCtD
Ketamine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000701	0.00721	CbGeAlD
Ketamine—OPRK1—cerebellum—peripheral nervous system neoplasm	0.000664	0.00682	CbGeAlD
Ketamine—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00065	0.00721	CcSEcCtD
Ketamine—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00065	0.00721	CcSEcCtD
Ketamine—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000641	0.00712	CcSEcCtD
Ketamine—DRD2—brainstem—peripheral nervous system neoplasm	0.000639	0.00657	CbGeAlD
Ketamine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000617	0.00685	CcSEcCtD
Ketamine—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.000613	0.00681	CcSEcCtD
Ketamine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000612	0.0068	CcSEcCtD
Ketamine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000612	0.0068	CcSEcCtD
Ketamine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000604	0.00671	CcSEcCtD
Ketamine—Shock—Isotretinoin—peripheral nervous system neoplasm	0.000602	0.00669	CcSEcCtD
Ketamine—Shock—Tretinoin—peripheral nervous system neoplasm	0.000602	0.00669	CcSEcCtD
Ketamine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000588	0.00653	CcSEcCtD
Ketamine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000583	0.00648	CcSEcCtD
Ketamine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000583	0.00648	CcSEcCtD
Ketamine—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000583	0.00648	CcSEcCtD
Ketamine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000576	0.00639	CcSEcCtD
Ketamine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000572	0.00635	CcSEcCtD
Ketamine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000572	0.00635	CcSEcCtD
Ketamine—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000568	0.00631	CcSEcCtD
Ketamine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.000566	0.00629	CcSEcCtD
Ketamine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000564	0.00627	CcSEcCtD
Ketamine—Cystitis noninfective—Epirubicin—peripheral nervous system neoplasm	0.000556	0.00617	CcSEcCtD
Ketamine—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.000552	0.00613	CcSEcCtD
Ketamine—Cystitis—Epirubicin—peripheral nervous system neoplasm	0.000549	0.0061	CcSEcCtD
Ketamine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000536	0.00595	CcSEcCtD
Ketamine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000536	0.00595	CcSEcCtD
Ketamine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000532	0.00591	CcSEcCtD
Ketamine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000532	0.00591	CcSEcCtD
Ketamine—Pain—Topotecan—peripheral nervous system neoplasm	0.000528	0.00586	CcSEcCtD
Ketamine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000525	0.00583	CcSEcCtD
Ketamine—Pain—Tretinoin—peripheral nervous system neoplasm	0.000523	0.00581	CcSEcCtD
Ketamine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000523	0.00581	CcSEcCtD
Ketamine—Pain—Melphalan—peripheral nervous system neoplasm	0.000517	0.00574	CcSEcCtD
Ketamine—Bladder pain—Epirubicin—peripheral nervous system neoplasm	0.000514	0.00571	CcSEcCtD
Ketamine—Cystitis noninfective—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.00571	CcSEcCtD
Ketamine—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.000511	0.00568	CcSEcCtD
Ketamine—Cystitis—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.00564	CcSEcCtD
Ketamine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000497	0.00552	CcSEcCtD
Ketamine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000492	0.00547	CcSEcCtD
Ketamine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000484	0.00538	CcSEcCtD
Ketamine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000477	0.00529	CcSEcCtD
Ketamine—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.00528	CcSEcCtD
Ketamine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000474	0.00527	CcSEcCtD
Ketamine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000464	0.00515	CcSEcCtD
Ketamine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000456	0.00507	CcSEcCtD
Ketamine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000456	0.00507	CcSEcCtD
Ketamine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000447	0.00496	CcSEcCtD
Ketamine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000442	0.00491	CcSEcCtD
Ketamine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000435	0.00483	CcSEcCtD
Ketamine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.00481	CcSEcCtD
Ketamine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000428	0.00475	CcSEcCtD
Ketamine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000426	0.00473	CcSEcCtD
Ketamine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00042	0.00466	CcSEcCtD
Ketamine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000418	0.00464	CcSEcCtD
Ketamine—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000413	0.00458	CcSEcCtD
Ketamine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000403	0.00448	CcSEcCtD
Ketamine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.0044	CcSEcCtD
Ketamine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000395	0.00439	CcSEcCtD
Ketamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000392	0.00436	CcSEcCtD
Ketamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000389	0.00432	CcSEcCtD
Ketamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000389	0.00432	CcSEcCtD
Ketamine—Rash—Topotecan—peripheral nervous system neoplasm	0.000389	0.00432	CcSEcCtD
Ketamine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000389	0.00432	CcSEcCtD
Ketamine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000388	0.00431	CcSEcCtD
Ketamine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000386	0.00428	CcSEcCtD
Ketamine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.00428	CcSEcCtD
Ketamine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.00428	CcSEcCtD
Ketamine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000386	0.00428	CcSEcCtD
Ketamine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000384	0.00427	CcSEcCtD
Ketamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000384	0.00426	CcSEcCtD
Ketamine—Pain—Vincristine—peripheral nervous system neoplasm	0.000382	0.00424	CcSEcCtD
Ketamine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.00424	CcSEcCtD
Ketamine—Rash—Melphalan—peripheral nervous system neoplasm	0.000381	0.00423	CcSEcCtD
Ketamine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000381	0.00423	CcSEcCtD
Ketamine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000377	0.00418	CcSEcCtD
Ketamine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000369	0.0041	CcSEcCtD
Ketamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000366	0.00407	CcSEcCtD
Ketamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000364	0.00404	CcSEcCtD
Ketamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000364	0.00404	CcSEcCtD
Ketamine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000362	0.00402	CcSEcCtD
Ketamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000359	0.00398	CcSEcCtD
Ketamine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000345	0.00383	CcSEcCtD
Ketamine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000344	0.00381	CcSEcCtD
Ketamine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000338	0.00376	CcSEcCtD
Ketamine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000338	0.00375	CcSEcCtD
Ketamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000318	0.00353	CcSEcCtD
Ketamine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000315	0.0035	CcSEcCtD
Ketamine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000315	0.00324	CbGeAlD
Ketamine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000315	0.00349	CcSEcCtD
Ketamine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000312	0.00321	CbGeAlD
Ketamine—Pain—Etoposide—peripheral nervous system neoplasm	0.00031	0.00344	CcSEcCtD
Ketamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000297	0.0033	CcSEcCtD
Ketamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000295	0.00327	CcSEcCtD
Ketamine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00325	CcSEcCtD
Ketamine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00324	CcSEcCtD
Ketamine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000291	0.00323	CcSEcCtD
Ketamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000284	0.00316	CcSEcCtD
Ketamine—Rash—Vincristine—peripheral nervous system neoplasm	0.000282	0.00313	CcSEcCtD
Ketamine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000282	0.00313	CcSEcCtD
Ketamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.00306	CcSEcCtD
Ketamine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.00299	CcSEcCtD
Ketamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000265	0.00295	CcSEcCtD
Ketamine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000255	0.00283	CcSEcCtD
Ketamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000251	0.00279	CcSEcCtD
Ketamine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000249	0.00277	CcSEcCtD
Ketamine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000249	0.00276	CcSEcCtD
Ketamine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000249	0.00276	CcSEcCtD
Ketamine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.00262	CcSEcCtD
Ketamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000235	0.00261	CcSEcCtD
Ketamine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000234	0.0026	CcSEcCtD
Ketamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00023	0.00256	CcSEcCtD
Ketamine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00255	CcSEcCtD
Ketamine—Rash—Etoposide—peripheral nervous system neoplasm	0.000228	0.00253	CcSEcCtD
Ketamine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000228	0.00253	CcSEcCtD
Ketamine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.00241	CcSEcCtD
Ketamine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00239	CcSEcCtD
Ketamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000215	0.00239	CcSEcCtD
Ketamine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00225	CcSEcCtD
Ketamine—Shock—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00222	CcSEcCtD
Ketamine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00221	CcSEcCtD
Ketamine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00215	CcSEcCtD
Ketamine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00211	CcSEcCtD
Ketamine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00208	CcSEcCtD
Ketamine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00205	CcSEcCtD
Ketamine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00199	CcSEcCtD
Ketamine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00196	CcSEcCtD
Ketamine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00195	CcSEcCtD
Ketamine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00193	CcSEcCtD
Ketamine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00181	CcSEcCtD
Ketamine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00178	CcSEcCtD
Ketamine—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000136	0.0014	CbGeAlD
Ketamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00143	CcSEcCtD
Ketamine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00142	CcSEcCtD
Ketamine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00142	CcSEcCtD
Ketamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00134	CcSEcCtD
Ketamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00133	CcSEcCtD
Ketamine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00131	CcSEcCtD
Ketamine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00131	CcSEcCtD
Ketamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00124	CcSEcCtD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	6.45e-05	0.000999	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MET—peripheral nervous system neoplasm	6.42e-05	0.000994	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—ERBB2—peripheral nervous system neoplasm	6.41e-05	0.000992	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MET—peripheral nervous system neoplasm	6.26e-05	0.000969	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	6.2e-05	0.00096	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—HRAS—peripheral nervous system neoplasm	6.19e-05	0.000959	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	6.18e-05	0.000957	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	6.18e-05	0.000957	CbGpPWpGaD
Ketamine—GRIN1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	6.18e-05	0.000957	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—HRAS—peripheral nervous system neoplasm	6.17e-05	0.000955	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.17e-05	0.000955	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	6.13e-05	0.000949	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.03e-05	0.000934	CbGpPWpGaD
Ketamine—GRIN2B—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	6.02e-05	0.000933	CbGpPWpGaD
Ketamine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	5.99e-05	0.000928	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	5.93e-05	0.000919	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.9e-05	0.000914	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.81e-05	0.0009	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—PTPN11—peripheral nervous system neoplasm	5.78e-05	0.000896	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.77e-05	0.000893	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—HRAS—peripheral nervous system neoplasm	5.76e-05	0.000891	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	5.67e-05	0.000878	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.66e-05	0.000877	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	5.65e-05	0.000875	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	5.61e-05	0.000869	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	5.61e-05	0.000869	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.51e-05	0.000853	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—AKT1—peripheral nervous system neoplasm	5.45e-05	0.000844	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	5.38e-05	0.000833	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	5.38e-05	0.000833	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	5.25e-05	0.000812	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	5.24e-05	0.000811	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	5.18e-05	0.000802	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.18e-05	0.000802	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	5.18e-05	0.000801	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.03e-05	0.000778	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.01e-05	0.000776	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—NRAS—peripheral nervous system neoplasm	5e-05	0.000774	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.96e-05	0.000769	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.95e-05	0.000766	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	4.92e-05	0.000761	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—NRAS—peripheral nervous system neoplasm	4.87e-05	0.000755	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.85e-05	0.00075	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.84e-05	0.000749	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—HRAS—peripheral nervous system neoplasm	4.73e-05	0.000732	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.71e-05	0.000729	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.7e-05	0.000727	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	4.69e-05	0.000726	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	4.68e-05	0.000725	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.68e-05	0.000724	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.6e-05	0.000713	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.59e-05	0.000711	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—ERBB2—peripheral nervous system neoplasm	4.57e-05	0.000708	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.49e-05	0.000695	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.49e-05	0.000695	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.47e-05	0.000693	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.38e-05	0.000678	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	4.36e-05	0.000675	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.34e-05	0.000671	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.32e-05	0.00067	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	4.3e-05	0.000666	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	4.25e-05	0.000659	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.2e-05	0.00065	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	4.18e-05	0.000648	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.13e-05	0.000639	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—HRAS—peripheral nervous system neoplasm	4.12e-05	0.000638	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.12e-05	0.000638	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	4.03e-05	0.000623	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—HRAS—peripheral nervous system neoplasm	4.02e-05	0.000622	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.94e-05	0.00061	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.93e-05	0.000608	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	3.93e-05	0.000608	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.92e-05	0.000608	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.9e-05	0.000603	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	3.79e-05	0.000587	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	3.67e-05	0.000568	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—HRAS—peripheral nervous system neoplasm	3.66e-05	0.000566	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.62e-05	0.000561	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—NRAS—peripheral nervous system neoplasm	3.57e-05	0.000552	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—HRAS—peripheral nervous system neoplasm	3.57e-05	0.000552	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—NRAS—peripheral nervous system neoplasm	3.48e-05	0.000539	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.44e-05	0.000533	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.4e-05	0.000526	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	3.33e-05	0.000515	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.33e-05	0.000515	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.32e-05	0.000513	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NTS—peripheral nervous system neoplasm	3.32e-05	0.000513	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.28e-05	0.000507	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.24e-05	0.000502	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	3.2e-05	0.000496	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	3.19e-05	0.000494	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CD55—peripheral nervous system neoplasm	3.18e-05	0.000492	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.17e-05	0.000491	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.1e-05	0.00048	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.1e-05	0.00048	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	3.07e-05	0.000476	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.06e-05	0.000474	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.91e-05	0.000451	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.91e-05	0.000451	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.86e-05	0.000443	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.85e-05	0.000441	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	2.82e-05	0.000436	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.78e-05	0.00043	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.73e-05	0.000423	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.72e-05	0.000421	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	2.7e-05	0.000418	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.65e-05	0.000411	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	2.64e-05	0.000409	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.64e-05	0.000408	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.61e-05	0.000404	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	2.6e-05	0.000403	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.59e-05	0.0004	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	2.57e-05	0.000398	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.56e-05	0.000396	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.54e-05	0.000394	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.53e-05	0.000391	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.52e-05	0.000391	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.51e-05	0.000389	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.45e-05	0.00038	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.43e-05	0.000376	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.39e-05	0.000371	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.35e-05	0.000364	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.33e-05	0.00036	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.32e-05	0.000359	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.32e-05	0.000359	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.3e-05	0.000357	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.3e-05	0.000356	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	2.29e-05	0.000355	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.27e-05	0.000351	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.26e-05	0.00035	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.25e-05	0.000348	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	2.23e-05	0.000346	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.22e-05	0.000343	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.21e-05	0.000342	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	2.2e-05	0.00034	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.13e-05	0.00033	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.13e-05	0.00033	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	2.12e-05	0.000328	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	2.1e-05	0.000325	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.09e-05	0.000324	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.07e-05	0.000321	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.06e-05	0.000319	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.05e-05	0.000318	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.03e-05	0.000315	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.02e-05	0.000313	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.02e-05	0.000313	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	2.02e-05	0.000312	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.97e-05	0.000304	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.88e-05	0.000291	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.87e-05	0.00029	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.74e-05	0.00027	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.72e-05	0.000266	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.72e-05	0.000266	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	1.71e-05	0.000265	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.71e-05	0.000264	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	1.7e-05	0.000264	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.68e-05	0.00026	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.66e-05	0.000257	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.64e-05	0.000254	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.63e-05	0.000252	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.61e-05	0.00025	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.6e-05	0.000248	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	1.6e-05	0.000248	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.53e-05	0.000237	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.51e-05	0.000234	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.49e-05	0.000231	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.49e-05	0.00023	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.45e-05	0.000225	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.44e-05	0.000223	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.44e-05	0.000223	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.42e-05	0.00022	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.41e-05	0.000219	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.4e-05	0.000217	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.4e-05	0.000216	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.39e-05	0.000215	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.38e-05	0.000213	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	1.36e-05	0.00021	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.32e-05	0.000204	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.31e-05	0.000202	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.3e-05	0.000202	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.28e-05	0.000199	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.27e-05	0.000197	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.26e-05	0.000195	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.26e-05	0.000195	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.22e-05	0.000188	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.2e-05	0.000186	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.2e-05	0.000186	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.19e-05	0.000185	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.18e-05	0.000183	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.17e-05	0.000182	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.17e-05	0.000181	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.16e-05	0.000179	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.12e-05	0.000173	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.12e-05	0.000173	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.11e-05	0.000172	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	1.11e-05	0.000171	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.1e-05	0.000171	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	1.09e-05	0.000168	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.06e-05	0.000164	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.05e-05	0.000163	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.02e-05	0.000158	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.01e-05	0.000157	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.69e-06	0.00015	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	9.65e-06	0.000149	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.44e-06	0.000146	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.29e-06	0.000144	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.22e-06	0.000143	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	9.16e-06	0.000142	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.05e-06	0.00014	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.03e-06	0.00014	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	9.01e-06	0.00014	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.9e-06	0.000138	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	8.84e-06	0.000137	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.65e-06	0.000134	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.57e-06	0.000133	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.5e-06	0.000132	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.92e-06	0.000123	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.86e-06	0.000122	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	7.74e-06	0.00012	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.42e-06	0.000115	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.39e-06	0.000114	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	7.28e-06	0.000113	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.18e-06	0.000111	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.16e-06	0.000111	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.09e-06	0.00011	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.74e-06	0.000104	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.69e-06	0.000104	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.56e-06	0.000102	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.5e-06	0.000101	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.5e-06	0.000101	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.26e-06	9.7e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.22e-06	9.63e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.95e-06	9.22e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.94e-06	9.2e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.83e-06	9.03e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.5e-06	8.51e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.49e-06	8.5e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.44e-06	8.43e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.26e-06	8.14e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.07e-06	7.85e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.64e-06	7.19e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	4.63e-06	7.16e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.16e-06	6.45e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.98e-06	6.17e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	3.53e-06	5.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.52e-06	5.45e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.99e-06	4.63e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.6e-06	4.03e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.43e-06	3.77e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.6e-06	2.48e-05	CbGpPWpGaD
